Fusion Proteins With Specificity for Type II Collagen and VEGF-A for the Treatment of Eye Diseases
Summary
The EPO published European patent application EP4326764A1, filed by Navigo Proteins GmbH, covering fusion proteins with specificity for type II collagen and VEGF-A for the treatment of eye diseases. The application names inventors Bosse-Doenecke, Eva; Gloser-Braeunig, Manja; Katzschmann, Anja; and Haupts, Ulrich. The patent is classified under C07K 16/22, C07K 14/78, and A61P 27/02, with all EPC contracting states designated.
“FUSION PROTEINS WITH SPECIFITY FOR TYPE II COLLAGEN AND VEGF-A FOR THE TREATMENT OF EYE DISEASES”
About this source
GovPing monitors EPO Patent Bulletin - Peptides (C07K) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 58 changes logged to date.
What changed
The EPO published European patent application EP4326764A1 filed by Navigo Proteins GmbH, covering fusion proteins with specificity for type II collagen and VEGF-A for use in treating eye diseases. The application names four inventors and is classified under IPC codes C07K 16/22 (immunoglobulins/anti-TGF-beta), C07K 14/78 (collagens/elastin), and A61P 27/02 (ophthalmologicals). All EPC contracting states are designated.
Affected parties include pharmaceutical and biotechnology companies developing fusion protein therapeutics for ophthalmological applications. Patent applicants and technology transfer offices should review the scope of claims in EP4326764A1 for potential freedom-to-operate considerations in the eye disease treatment space.
Archived snapshot
Apr 25, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
FUSION PROTEINS WITH SPECIFITY FOR TYPE II COLLAGEN AND VEGF-A FOR THE TREATMENT OF EYE DISEASES
Publication EP4326764A1 Kind: A1 Apr 15, 2026
Applicants
NAVIGO PROTEINS GMBH
Inventors
BOSSE-DOENECKE, Eva, GLOSER-BRAEUNIG, Manja, KATZSCHMANN, Anja, HAUPTS, Ulrich
IPC Classifications
C07K 16/22 20060101AFI20221028BHEP C07K 14/78 20060101ALI20221028BHEP A61P 27/02 20060101ALI20221028BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Parties
Related changes
Get daily alerts for EPO Patent Bulletin - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.